BioSpace News Archive

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that the Company will present an overview of the company at the Three Part Advisors 2019 Southwest IDEAS Investor Conference on Wednesday, November 20, 2019

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that the company and its collaborators from the Whitehead Institute for Biomedical Research will present on the identification of core drivers of metastasis in triple-negative breast cancer (TNBC) in a poster presentation at the 2019 San Antonio Breast Cancer Symposium (SABCS), taking place December 10-14 in San Antonio, Texas.

AVEO Oncology (NASDAQ: AVEO) today announced the appointment of Scarlett Spring to its Board of Directors.

Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today announced that the European Medicines Agency (EMA) has granted access to support through the PRIME (PRIority MEdicines) program for danicopan (ACH-4471) in the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in patients who are not adequately responding to a C5 inhibitor.

OpGen, Inc. (Nasdaq: OPGN) announced today that the Center for Disease Control (CDC) has released updated data increasing the number of deaths in the United States (U.S.) from antibiotic-resistant bacteria and fungi, and highlighting the continuing threat of rising antibiotic resistance.

Progressive Care Inc., a personalized healthcare services and technology company, is excited to report another month of exceptional growth and expanding margins.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“Company”), a biotechnology company specializing in the development of novel treatments for brain tumors, completed an agreement with Houston Pharmaceuticals, Inc. (“HPI”) to obtain the rights to a worldwide, exclusive royalty-bearing, license for the chemical compound commonly known as Berubicin

Jay D. Raman, MD, FACS, of Penn State Health has been selected by a search committee and approved by the AUA Board of Directors as the new Chair of the AUA Office of Education.

The Board of Directors of Nordic Nanovector ASA has on 19th November 2019 resolved to grant Dr Gabriele Elbl, Vice President Global Regulatory Affairs, 30,000 Performance Share Units in connection with her appointment and under the Company’s equity incentive plan that was approved at the Company’s annual general meeting held on 25 April 2019

Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise to the visitors, at the high impact healthcare trade shows, MEDICA, in Dusseldorf, Germany, starting from Nov 18, 2019.